Gabriel Lopez‐berestein
#123,887
Most Influential Person Now
Gabriel Lopez‐berestein's AcademicInfluence.com Rankings
Gabriel Lopez‐beresteinphilosophy Degrees
Philosophy
#5721
World Rank
#8608
Historical Rank
Logic
#2947
World Rank
#4029
Historical Rank
Gabriel Lopez‐beresteinbiology Degrees
Biology
#7696
World Rank
#10654
Historical Rank
Biochemistry
#1068
World Rank
#1183
Historical Rank
Download Badge
Philosophy Biology
Why Is Gabriel Lopez‐berestein Influential?
(Suggest an Edit or Addition)Gabriel Lopez‐berestein's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes (2008) (2360)
- MicroRNAs in body fluids—the mix of hormones and biomarkers (2011) (1301)
- Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma (2006) (1059)
- RNA interference in the clinic: challenges and future directions (2011) (737)
- Dicer, Drosha, and outcomes in patients with ovarian cancer. (2008) (708)
- Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. (2005) (670)
- Paraneoplastic thrombocytosis in ovarian cancer. (2012) (636)
- Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206. (2005) (565)
- miRNA Deregulation in Cancer Cells and the Tumor Microenvironment. (2016) (498)
- Correction: Corrigendum: Src activation by β-adrenoreceptors is a key switch for tumour metastasis (2013) (419)
- Targeting the pro-death and pro-survival functions of autophagy as novel therapeutic strategies in cancer (2010) (413)
- Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. (1985) (401)
- Regulation of tumor angiogenesis by EZH2. (2010) (381)
- Preclinical and clinical development of siRNA-based therapeutics. (2015) (375)
- Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer (2010) (360)
- Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. (2013) (359)
- Tumour angiogenesis regulation by the miR-200 family (2013) (351)
- microRNA Therapeutics in Cancer — An Emerging Concept (2016) (335)
- Liposomal siRNA nanocarriers for cancer therapy. (2014) (329)
- miR-34a Blocks Osteoporosis and Bone Metastasis by Inhibiting Osteoclastogenesis and Tgif2 (2014) (323)
- Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy (2006) (322)
- Sustained small interfering RNA delivery by mesoporous silicon particles. (2010) (288)
- Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. (1983) (279)
- Hematogenous metastasis of ovarian cancer: rethinking mode of spread. (2014) (265)
- Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth. (2008) (261)
- Targeting Stromal Glutamine Synthetase in Tumors Disrupts Tumor Microenvironment-Regulated Cancer Cell Growth. (2016) (252)
- Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells (2008) (249)
- Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis. (2010) (247)
- Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles (2010) (245)
- Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer (2014) (243)
- A Core Human Primary Tumor Angiogenesis Signature Identifies the Endothelial Orphan Receptor ELTD1 as a Key Regulator of Angiogenesis (2013) (230)
- RNAi Therapies: Drugging the Undruggable (2014) (217)
- Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma. (2007) (208)
- Nanomedicine based approaches for the delivery of siRNA in cancer (2010) (205)
- Treatment of hepatosplenic candidiasis with liposomal-amphotericin B. (1987) (203)
- Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial. (2001) (200)
- Cystathionine Beta-Synthase (CBS) Contributes to Advanced Ovarian Cancer Progression and Drug Resistance (2013) (199)
- Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles. (2011) (190)
- Treatment of systemic fungal infections with liposomal amphotericin B. (1989) (188)
- Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells. (1984) (188)
- TP53 loss creates therapeutic vulnerability in colorectal cancer (2015) (188)
- Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver. (2008) (163)
- Stress Effects on FosB- and Interleukin-8 (IL8)-driven Ovarian Cancer Growth and Metastasis* (2010) (162)
- Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA. (2008) (161)
- An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic. (2007) (152)
- miR-205 acts as a tumor radiosensitizer by targeting ZEB1 and Ubc13 (2014) (152)
- Hypoxia Mediated Downregulation of miRNA Biogenesis Promotes Tumor Progression (2014) (152)
- Autocrine Effects of Tumor-Derived Complement (2014) (152)
- Src activation by β-adrenoreceptors is a key switch for tumor metastasis (2012) (150)
- Biologic and immunomodulatory events after CTLA‐4 blockade with ticilimumab in patients with advanced malignant melanoma (2006) (150)
- RNA interference-based therapy and its delivery systems (2018) (148)
- Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment. (2013) (143)
- JAK2-binding long noncoding RNA promotes breast cancer brain metastasis (2017) (143)
- Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer. (2007) (142)
- Stress Hormones Regulate Interleukin-6 Expression by Human Ovarian Carcinoma Cells through a Src-dependent Mechanism* (2007) (142)
- Platelets reduce anoikis and promote metastasis by activating YAP1 signaling (2017) (141)
- Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer (2018) (140)
- Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2. (2016) (133)
- Tissue Transglutaminase Inhibits Autophagy in Pancreatic Cancer Cells (2007) (132)
- N-Methyl-d-aspartate Receptor- and Calpain-mediated Proteolytic Cleavage of K+-Cl− Cotransporter-2 Impairs Spinal Chloride Homeostasis in Neuropathic Pain* (2012) (130)
- SIK2 is a centrosome kinase required for bipolar mitotic spindle formation that provides a potential target for therapy in ovarian cancer. (2010) (128)
- Therapeutic Targeting of ATP7B in Ovarian Carcinoma (2009) (123)
- Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice. (1984) (123)
- Salt-Inducible Kinase 2 Couples Ovarian Cancer Cell Metabolism with Survival at the Adipocyte-Rich Metastatic Niche. (2016) (122)
- Interaction of nuclear proteins with an AP‐1/CRE‐like promoter sequence in the human TNF‐α gene (1994) (122)
- Synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia. (2002) (122)
- Phase I trial of intratumoral liposome E1A gene therapy in patients with recurrent breast and head and neck cancer. (2001) (121)
- The Extracellular RNA Communication Consortium: Establishing Foundational Knowledge and Technologies for Extracellular RNA Research (2019) (120)
- Clinical pharmacology of 99mTc-labeled liposomes in patients with cancer. (1984) (120)
- Liposomal Bcl-2 antisense oligonucleotides enhance proliferation, sensitize acute myeloid leukemia to cytosine-arabinoside, and induce apoptosis independent of other antiapoptotic proteins. (2000) (119)
- Par-4 Transcriptionally Regulates Bcl-2 through a WT1-binding Site on the bcl-2 Promoter* (2003) (115)
- Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers (2016) (113)
- Therapeutic Significance of Elevated Tissue Transglutaminase Expression in Pancreatic Cancer (2008) (113)
- FABP4 as a key determinant of metastatic potential of ovarian cancer (2018) (112)
- Phase I clinical and pharmacological study of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II). (1990) (111)
- Targeting the Notch Ligand Jagged1 in Both Tumor Cells and Stroma in Ovarian Cancer (2011) (111)
- Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells. (2016) (111)
- Nuclear Factor-κB p65/relA Silencing Induces Apoptosis and Increases Gemcitabine Effectiveness in a Subset of Pancreatic Cancer Cells (2008) (111)
- Role of vascular congestion in cisplatin-induced acute renal failure in the rat. (1992) (110)
- Intraperitoneal delivery of liposomal siRNA for therapy of advanced ovarian cancer (2006) (109)
- Comparative proteomic analysis of all-trans-retinoic acid treatment reveals systematic posttranscriptional control mechanisms in acute promyelocytic leukemia. (2004) (108)
- Altered tissue distribution of amphotericin B by liposomal encapsulation: comparison of normal mice to mice infected with Candida albicans. (1984) (107)
- Clinical and biological significance of tissue transglutaminase in ovarian carcinoma. (2008) (107)
- Molecular remissions induced by liposomal-encapsulated all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia. (1999) (106)
- Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers. (2015) (103)
- Biological roles of the Delta family Notch ligand Dll4 in tumor and endothelial cells in ovarian cancer. (2011) (103)
- Experimental Trichosporon infection in persistently granulocytopenic rabbits: implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosis. (1992) (103)
- A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer (2016) (103)
- Liposomes as carriers of antimicrobial agents (1987) (102)
- Calcium Dependent FAK/CREB/TNNC1 Signaling Mediates the Effect of Stromal MFAP5 on Ovarian Cancer Metastatic Potential (2014) (102)
- FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair. (2012) (102)
- Targeted Silencing of Elongation Factor 2 Kinase Suppresses Growth and Sensitizes Tumors to Doxorubicin in an Orthotopic Model of Breast Cancer (2012) (100)
- Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeys (1986) (99)
- GRB2: a pivotal protein in signal transduction. (2001) (99)
- Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy (2015) (98)
- MiR‐506 inhibits multiple targets in the epithelial‐to‐mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer (2015) (97)
- Src activation by b-adrenoreceptors is a key switch for tumour metastasis (2013) (96)
- Enhancing Chemotherapy Response with Sustained EphA2 Silencing Using Multistage Vector Delivery (2013) (95)
- Yes‐associated protein 1 and transcriptional coactivator with PDZ‐binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma (2016) (95)
- In vitro antifungal activities of amphotericin B and liposome-encapsulated amphotericin B (1984) (91)
- Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance (2017) (91)
- Bcl-2 inhibits p53 nuclear import following DNA damage (1997) (90)
- Roles of liposome composition and temperature in distribution of amphotericin B in serum lipoproteins (1993) (90)
- 2′-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity (2014) (89)
- MicroRNA therapeutics: principles, expectations, and challenges (2011) (89)
- FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal. (2016) (88)
- Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis. (2015) (88)
- Telomere Dysfunction Induces Sirtuin Repression that Drives Telomere-Dependent Disease. (2019) (87)
- Decreased toxicity of liposomal amphotericin B due to association of amphotericin B with high-density lipoproteins: role of lipid transfer protein. (1994) (87)
- Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered ATRA in healthy volunteers. (2003) (87)
- Development of liposomal polyene antibiotics: an historical perspective. (2003) (85)
- Hepatosplenic fungal infection: CT and pathologic evaluation after treatment with liposomal amphotericin B. (1986) (85)
- Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression (2015) (85)
- Cardiopulmonary toxicity after liposomal amphotericin B infusion. (1991) (84)
- Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers (2011) (83)
- Enhancing Chemotherapy Response with Bmi-1 Silencing in Ovarian Cancer (2011) (83)
- Influence of lipoproteins on renal cytotoxicity and antifungal activity of amphotericin B (1994) (83)
- Pharmacokinetics, tissue distribution, and toxicity of free and liposomal amphotericin B in diabetic rats. (1990) (82)
- The activation of human monocytes by liposome-encapsulated muramyl dipeptide analogues. (1983) (81)
- N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration (2017) (81)
- Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (−) and ER (+) Breast Cancer (2013) (81)
- Toxicity and therapeutic effects in mice of liposome-encapsulated nystatin for systemic fungal infections (1987) (81)
- Induction of differentiation in myeloid leukemia cell lines and acute promyelocytic leukemia cells by liposomal all-trans-retinoic acid. (1993) (80)
- Expression of tissue transglutaminase in cultured monocytic leukemia (THP-1) cells during differentiation. (1986) (80)
- MYC Targeted Long Noncoding RNA DANCR Promotes Cancer in Part by Reducing p21 Levels. (2018) (79)
- Synergism between human recombinant gamma-interferon and muramyl dipeptide encapsulated in liposomes for activation of antitumor properties in human blood monocytes. (1985) (78)
- Her2/neu induces all-transretinoic acid (ATRA) resistance in breast cancer cells (2002) (78)
- Pharmacokinetic profile of ABELCET (amphotericin B lipid complex injection): combined experience from phase I and phase II studies (1997) (77)
- Nanotechnology in cancer therapy (2013) (77)
- Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors. (2011) (76)
- Formulation, toxicity, and antifungal activity in vitro of liposome-encapsulated nystatin as therapeutic agent for systemic candidiasis (1987) (76)
- Tat‐activating regulatory DNA‐binding protein regulates glycolysis in hepatocellular carcinoma by regulating the platelet isoform of phosphofructokinase through microRNA 520 (2013) (76)
- Differentiation therapy for hepatocellular carcinoma: Multifaceted effects of miR‐148a on tumor growth and phenotype and liver fibrosis (2016) (76)
- Chitosan hydrogel for localized gene silencing (2011) (74)
- Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA) (2017) (74)
- Functional Roles of Src and Fgr in Ovarian Carcinoma (2011) (73)
- Exosomal Non-Coding RNAs: Diagnostic, Prognostic and Therapeutic Applications in Cancer (2015) (72)
- Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer. (2016) (72)
- Treatment of invasive aspergillus sinusitis with liposomal‐amphotericin B (1987) (72)
- Molecular Biomarkers of Residual Disease after Surgical Debulking of High-Grade Serous Ovarian Cancer (2014) (71)
- PKCδ and Tissue Transglutaminase are Novel Inhibitors of Autophagy in Pancreatic Cancer Cells (2007) (71)
- Role of M2, M3, and M4 muscarinic receptor subtypes in the spinal cholinergic control of nociception revealed using siRNA in rats (2009) (70)
- MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase (2016) (70)
- Liposomal amphotericin B in the treatment of fungal infections. (1986) (70)
- Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis. (2010) (70)
- Silencing Survivin Splice Variant 2B Leads to Antitumor Activity in Taxane-Resistant Ovarian Cancer (2011) (69)
- Therapeutic Silencing of KRAS Using Systemically Delivered siRNAs (2014) (69)
- Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans retinoic acid. (1996) (68)
- Adrenergic regulation of monocyte chemotactic protein 1 leads to enhanced macrophage recruitment and ovarian carcinoma growth (2014) (68)
- Erythropoietin Stimulates Tumor Growth via EphB4. (2015) (67)
- Downregulation of Wilms' tumor 1 protein inhibits breast cancer proliferation. (2002) (67)
- Liposome encapsulation circumvents the hepatic clearance mechanisms of all-trans-retinoic acid. (1994) (67)
- Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma. (2005) (66)
- Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer (2020) (66)
- The previously undescribed ZKSCAN3 (ZNF306) is a novel "driver" of colorectal cancer progression. (2008) (66)
- Sustained adrenergic signaling leads to increased metastasis in ovarian cancer via increased PGE2 synthesis (2015) (65)
- Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer (2013) (65)
- Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells (1999) (64)
- Novel strategies for reversing platinum resistance. (2009) (64)
- Macrophages Facilitate Resistance to Anti-VEGF Therapy by Altered VEGFR Expression (2017) (63)
- Effects of sterols on the therapeutic efficacy of liposomal amphotericin B in murine candidiasis. (1983) (63)
- Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer (2012) (63)
- Adrenergic Stimulation of DUSP1 Impairs Chemotherapy Response in Ovarian Cancer (2015) (63)
- Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer (2016) (63)
- Nanotechnology: Future of Oncotherapy (2015) (62)
- Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses. (2001) (62)
- Silk fibroin mediated delivery of liposomal emodin to breast cancer cells. (2007) (61)
- Notch3 pathway alterations in ovarian cancer. (2014) (60)
- Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice (1997) (60)
- Monocyte subpopulations in angiogenesis. (2014) (60)
- Dual Suppressive Effect of miR-34a on the FOXM1/eEF2-Kinase Axis Regulates Triple-Negative Breast Cancer Growth and Invasion (2018) (58)
- Treatment and prophylaxis of experimental liver metastases of M5076 reticulosarcoma with cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) encapsulated in multilamellar vesicles. (1987) (57)
- Dual targeting of EphA2 and FAK in ovarian carcinoma (2009) (57)
- Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer (2013) (56)
- all‐trans‐Retinoic acid‐induced expression and regulation of retinoic acid 4‐hydroxylase (CYP26) in human promyelocytic leukemia (2002) (56)
- GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma. (2020) (55)
- Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer (2015) (55)
- Endoglin (CD105) Contributes to Platinum Resistance and Is A Target for Tumor-Specific Therapy in Epithelial Ovarian Cancer (2012) (54)
- Bone protection by inhibition of microRNA-182 (2018) (54)
- Uptake of liposomes and liposome-encapsulated muramyl dipeptide by human peripheral blood monocytes. (1982) (53)
- Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction. (2018) (53)
- Liposomal delivery of methylphosphonate antisense oligodeoxynucleotides in chronic myelogenous leukemia. (1994) (53)
- Single-agent liposomal all-trans retinoic acid can cure some patients with untreated acute promyelocytic leukemia: an update of The University of Texas M. D. Anderson Cancer Center Series (2006) (51)
- Highly Specific Targeting of the TMPRSS2/ERG Fusion Gene Using Liposomal Nanovectors (2012) (51)
- A Phase I multicenter study of E1A gene therapy for patients with metastatic breast cancer and epithelial ovarian cancer that overexpresses HER-2/neu or epithelial ovarian cancer. (1998) (51)
- Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models (2017) (51)
- Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4 (2016) (50)
- Effect of liposomal amphotericin B on murine macrophages and lymphocytes (1985) (50)
- The potential of drug-carrying immunoliposomes as anticancer agents. Commentary re: J. W. Park et al., Anti-HER2 immunoliposomes: enhanced efficacy due to targeted delivery. Clin. Cancer Res., 8: 1172-1181, 2002. (2002) (49)
- c-Jun-NH2-kinase-1 Inhibition Leads to Antitumor Activity in Ovarian Cancer (2009) (49)
- Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell death. (2011) (49)
- miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer. (2019) (49)
- Antagonism of tumoral prolactin receptor promotes autophagy-related cell death. (2014) (47)
- Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancer. (2012) (47)
- STAMP2 increases oxidative stress and is critical for prostate cancer (2015) (46)
- Role of Increased n-acetylaspartate Levels in Cancer. (2016) (46)
- Safety, pharmacokinetics, and tissue distribution of liposomal P-ethoxy antisense oligonucleotides targeted to Bcl-2. (1999) (46)
- Liposomes as Carriers of Antifungal Drugs (1988) (45)
- ATP11B mediates platinum resistance in ovarian cancer. (2013) (45)
- Focal adhesion kinase (2014) (45)
- Interaction of nuclear proteins with an AP-1/CRE-like promoter sequence in the human TNF-alpha gene. (1994) (44)
- Prophylaxis of Candida albicans infection in neutropenic mice with liposome-encapsulated amphotericin B (1984) (44)
- The ZNF304-integrin axis protects against anoikis in cancer (2015) (44)
- Concentrations in serum and distribution in tissue of free and liposomal amphotericin B in rats during continuous intralipid infusion (1994) (44)
- Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer (2018) (43)
- Rational drug redesign to overcome drug resistance in cancer therapy: imatinib moving target. (2007) (43)
- Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancers. (2014) (43)
- Role of Platelet-Derived Tgfβ1 in the Progression of Ovarian Cancer (2017) (43)
- Regulation of a highly specific retinoic acid-4-hydroxylase (CYP26A1) enzyme and all-trans-retinoic acid metabolism in human intestinal, liver, endothelial, and acute promyelocytic leukemia cells (2005) (43)
- Pentoxifylline in amphotericin B toxicity rat model (1990) (42)
- Targeting KRas-dependent tumor growth, circulating tumor cells and metastasis in vivo by clinically significant miR-193a-3p (2016) (41)
- Therapeutic Targeting of PELP1 Prevents Ovarian Cancer Growth and Metastasis (2011) (41)
- Liposomal siRNA for ovarian cancer. (2009) (41)
- Grb2 downregulation leads to Akt inactivation in heregulin-stimulated and ErbB2-overexpressing breast cancer cells (2000) (40)
- Converging Evidence for Efficacy from Parallel EphB4-Targeted Approaches in Ovarian Carcinoma (2010) (40)
- Distribution of technetium-99m-labeled multilamellar liposomes in patients with Hodgkin's disease. (1985) (40)
- Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation (2018) (39)
- PKC delta and tissue transglutaminase are novel inhibitors of autophagy in pancreatic cancer cells. (2007) (39)
- Phagocyte transport as mechanism for enhanced therapeutic activity of liposomal amphotericin B. (1994) (39)
- Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver (2008) (38)
- Targeting p70S6K Prevented Lung Metastasis in a Breast Cancer Xenograft Model (2010) (38)
- Safety studies of the intraperitoneal injection of E1A–liposome complex in mice (1997) (38)
- Selective Toxicity and Enhanced Therapeutic Index of Liposomal Polyene Antibiotics in Systemic Fungal Infections (1985) (38)
- Bcl-2-related antisense therapy. (2002) (38)
- Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling (2018) (38)
- Neuropilin-2 Mediated β-Catenin Signaling and Survival in Human Gastro-Intestinal Cancer Cell Lines (2011) (37)
- Apoptotic induction in transformed follicular lymphoma cells by Bcl-2 downregulation. (1998) (37)
- Retinoid-mediated inhibition of cell growth with stimulation of apoptosis in aggressive B-cell lymphomas. (1997) (37)
- HN1L Promotes Triple-Negative Breast Cancer Stem Cells through LEPR-STAT3 Pathway (2017) (37)
- ΔNp63/DGCR8-Dependent MicroRNAs Mediate Therapeutic Efficacy of HDAC Inhibitors in Cancer. (2016) (36)
- Serum predominantly activates MAPK and Akt kinases in EGFR‐ and ErbB2‐over‐expressing cells, respectively (2000) (36)
- Identifying and targeting angiogenesis-related microRNAs in ovarian cancer (2019) (36)
- Expression of c-fos, c-myb, and c-myc in human monocytes: correlation with monocytic differentiation. (1987) (36)
- EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer. (2014) (36)
- Clodronate inhibits tumor angiogenesis in mouse models of ovarian cancer (2014) (36)
- Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens. (2017) (36)
- Characteristics of lipid-based formulations that influence their biological behavior in the plasma of patients. (1996) (36)
- A-to-I-edited miRNA-379-5p inhibits cancer cell proliferation through CD97-induced apoptosis. (2019) (35)
- Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer (2015) (34)
- Up-regulation of Cavβ3 Subunit in Primary Sensory Neurons Increases Voltage-activated Ca2+ Channel Activity and Nociceptive Input in Neuropathic Pain* (2011) (34)
- HSP70 Inhibition Synergistically Enhances the Effects of Magnetic Fluid Hyperthermia in Ovarian Cancer (2017) (34)
- Liposome-incorporated Grb2 antisense oligodeoxynucleotide increases the survival of mice bearing bcr-abl-positive leukemia xenografts. (2007) (34)
- Stimulation of macrophage protease secretion via liposomal delivery of muramyl dipeptide derivatives to intracellular sites. (1984) (34)
- Toxicity and antitumor activity of cis-bis-cyclopentenecarboxylato-1,2-diaminocyclohexane platinum(II) encapsulated in multilamellar vesicles. (1986) (34)
- Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancer. (2013) (33)
- Presence of Circulating miR-145, miR-155, and miR-382 in Exosomes Isolated from Serum of Breast Cancer Patients and Healthy Donors (2019) (33)
- Distribution and pharmacology of intravenous 99mTc-labeled multilamellar liposomes in rats and mice. (1984) (32)
- Differential Effects of EGFL6 on Tumor versus Wound Angiogenesis. (2017) (32)
- The ADMR Receptor Mediates the Effects of Adrenomedullin on Pancreatic Cancer Cells and on Cells of the Tumor Microenvironment (2009) (32)
- Interferon-gamma requires serum retinoids to promote the expression of tissue transglutaminase in cultured human blood monocytes. (1985) (32)
- Kinetics and function of tumor cytotoxic factor(s) produced by human blood monocytes activated to the tumoricidal state. (1985) (32)
- Phase 1 trial of monthly doses of the human anti-CTLA4 monoclonal antibody CP-675,206 in patients with advanced melanoma (2005) (32)
- The past, present, and future uses of liposomes in treating infectious diseases. (1995) (31)
- Pharmacokinetic and pharmacodynamic evaluation of liposomal cyclosporine (1989) (30)
- Metronomic Docetaxel in PRINT Nanoparticles and EZH2 Silencing Have Synergistic Antitumor Effect in Ovarian Cancer (2014) (30)
- Characterization of small and large human peripheral blood monocytes: effects of in vitro maturation on hydrogen peroxide release and on the response to macrophage activators. (1986) (30)
- Strategies for in vivo siRNA delivery in cancer. (2008) (30)
- Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP) (2018) (30)
- Regulation of hnRNPA1 by microRNAs controls the miR-18a–K-RAS axis in chemotherapy-resistant ovarian cancer (2017) (30)
- Linalool-Incorporated Nanoparticles as a Novel Anticancer Agent for Epithelial Ovarian Carcinoma (2016) (29)
- ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast Cancer. (2018) (29)
- Cardiotoxicity due to cancer therapy. (2011) (29)
- Grb2 depletion under non-stimulated conditions inhibits PTEN, promotes Akt-induced tumor formation and contributes to poor prognosis in ovarian cancer (2016) (28)
- Inhibition of Grb2 and Crkl proteins results in growth inhibition of Philadelphia chromosome positive leukemic cells. (1997) (28)
- PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis (2019) (28)
- Inhibition of HIV replication by liposomal encapsulated amphotericin B. (1989) (28)
- Liposomal-all-trans-retinoic Acid in Treatment of Acute Promyelocytic Leukemia (2002) (28)
- In vitro evaluation of liposomal cyclosporine (1989) (27)
- Liposome-encapsulated muramyl dipeptide analogue enhances non-specific host immunity (1986) (27)
- CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and Apoptosis (2015) (27)
- Liposomal delivery of oligodeoxynucleotides. (1996) (27)
- Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability (2018) (27)
- Pan-cancer genomic analysis links 3’UTR DNA methylation with increased gene expression in T cells (2019) (26)
- Biological significance of HORMA domain containing protein 1 (HORMAD1) in epithelial ovarian carcinoma. (2013) (26)
- Aerosolized amphotericin B-liposomes for treatment of systemic Candida infections in mice (1994) (25)
- The interaction of liposomal amphotericin B and serum lipoproteins within the biological milieu. (1994) (25)
- Bisphosphonates Inhibit Stellate Cell Activity and Enhance Antitumor Effects of Nanoparticle Albumin–Bound Paclitaxel in Pancreatic Ductal Adenocarcinoma (2014) (24)
- A distinct element involved in lipopolysaccharide activation of the tumor necrosis factor-alpha promoter in monocytes. (2000) (24)
- Centrifugal elutriation as a method for isolation of large numbers of functionally intact human peripheral blood monocytes (1986) (24)
- Protective effect of liposomal-amphotericin B against C. albicans infection in mice. (1985) (24)
- miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas (2017) (24)
- The influence of serum lipoproteins on the pharmacokinetics and pharmacodynamics of lipophilic drugs and drug carriers. (1993) (24)
- FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair. (2019) (23)
- Liposomal hamycin: reduced toxicity and improved antifungal efficacy in vitro and in vivo. (1991) (22)
- Relaxin/RXFP1 Signaling in Prostate Cancer Progression (2009) (22)
- Downregulation of the c‐MYC target gene, peroxiredoxin III, contributes to arsenic trioxide‐induced apoptosis in acute promyelocytic leukemia (2009) (22)
- Gain-of-function p53 protein transferred via small extracellular vesicles promotes conversion of fibroblasts to a cancer-associated phenotype (2021) (21)
- Distribution of radiolabeled multilamellar liposomes injected intralymphatically and subcutaneously. (1985) (21)
- Erratum: Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer (2016) (21)
- Pharmacokinetics, tissue distribution, and toxicology of tretinoin incorporated in liposomes (1994) (21)
- Suppression of macrophage cytostatic activation by serum retinoids: a possible role for transglutaminase. (1987) (21)
- Liposomes in the therapy of infectious diseases and cancer (1989) (21)
- Potential curability of newly diagnosed acute promyelocytic leukemia without use of chemotherapy: the example of liposomal all-trans retinoic acid. (2005) (21)
- Tissue distribution and in vivo immunosuppressive activity of liposomal cyclosporine. (1991) (20)
- ATRA(ouble) in the treatment of acute promyelocytic leukemia. (2001) (20)
- Protease inhibitors block the macrophage-mediated inhibition of tumor cell mitochondrial respiration. (1990) (20)
- Induction of Adenosine Deaminase and 5′ Nucleotidase Activity in Cultured Human Blood Monocytes and Monocytic Leukemia (THP‐1) Cells by Differentiating Agents (1988) (20)
- Long non-coding RNAs in ovarian cancer: expression profile and functional spectrum (2019) (19)
- 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast Cancers (2019) (19)
- Mononuclear Phagocytes in Cell Biology (1992) (19)
- The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers (2018) (19)
- Disseminated visceral fusariosis treated with amphotericin B-phospholipid complex. (1993) (19)
- Synergistic antifungal activity and reduced toxicity of liposomal amphotericin B combined with gramicidin S or NF (1987) (18)
- PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer (2018) (18)
- RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site (2021) (18)
- Pharmacokinetics of liposomal nystatin in patients with human immunodeficiency virus infection. (1993) (18)
- Induction of Tissue Transglutaminase in Human Peripheral Blood Monocytes by Intracellular Delivery of Retinoids (1987) (18)
- EphA2 gene targeting using neutral liposomal small interfering RNA (EPHARNA) delivery: A phase I clinical trial. (2017) (18)
- Therapeutic silencing of HPV 16 E7 by systemic administration of siRNA-neutral DOPC nanoliposome in a murine cervical cancer model with obesity. (2015) (18)
- Acquired immune deficiency syndrome in a patient with prior sarcoidosis: case report with monocyte function studies. (1985) (17)
- Computational Study of Nanomaterials: From Large-Scale Atomistic Simulations to Mesoscopic Modeling (2015) (17)
- Comparative functional analysis of lymphocytes and monocytes from plateletapheresis (1983) (17)
- Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers. (2016) (17)
- Pharmacokinetics of cyclosporine in bone marrow transplantation: longitudinal characterization of drug in lipoprotein fractions. (1992) (17)
- Effect of Retinoids on the Release and Gene Expression of Tumor Necrosis Factor‐α in Human Peripheral Blood Monocytes (1990) (17)
- ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer (2021) (17)
- Chitosan Nanoparticles for miRNA Delivery. (2017) (17)
- Phase 1 clinical trial of anti-CTLA4 human monoclonal antibody CP-675,206 in patients (pts) with advanced solid malignancies. (2004) (17)
- Delivery of negatively charged liposomes into the atherosclerotic plaque of apolipoprotein E-deficient mouse aortic tissue (2014) (16)
- Prophylaxis of murine candidiasis via application of liposome-encapsulated amphotericin B and a muramyl dipeptide analog, alone and in combination (1985) (16)
- Independence of the Pattern of Early Cytokine Release From Autoregulation by Nitric Oxide (1991) (16)
- Cellular Pharmacology of P-ethoxy Antisense Oligonucleotides Targeted to Bcl-2 in a Follicular Lymphoma Cell Line (2003) (15)
- Death-associated protein 5 (DAP5/p97/NAT1) contributes to retinoic acid-induced granulocytic differentiation and arsenic trioxide-induced apoptosis in acute promyelocytic leukemia (2008) (15)
- Quaking orchestrates a post-transcriptional regulatory network of endothelial cell cycle progression critical to angiogenesis and metastasis (2019) (15)
- Mutant Bik expression mediated by the enhanced minimal topoisomerase IIα promoter selectively suppressed breast tumors in an animal model (2006) (15)
- Disposition and toxicity of amphotericin-B in the hyperlipidemic Zucker rat model. (1990) (15)
- Modification of Amphotericin B's Therapeutic Index by Increasing Its Association with Serum High‐Density Lipoproteins a (1994) (14)
- Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancer (2017) (14)
- Blockade of CDK7 Reverses Endocrine Therapy Resistance in Breast Cancer (2020) (14)
- A multicenter Phase II study of the intravenous administration of liposomal tretinoin in patients with acquired immunodeficiency syndrome‐associated Kaposi's sarcoma (2002) (14)
- The hidden role of paxillin: localization to nucleus promotes tumor angiogenesis (2020) (14)
- Cellular uptake and localization of liposomal-methylphosphonate oligodeoxynucleotides (1996) (14)
- Conversion of RNA Aptamer into Modified DNA Aptamers Provides for Prolonged Stability and Enhanced Antitumor Activity. (2021) (14)
- Effects of Intralipid infusion on rat serum lipoproteins (1994) (13)
- CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance (2021) (13)
- Pharmacokinetics, Tissue Distribution, and Safety of P-Ethoxy Oligonucleotides Incorporated in Liposomes (1998) (13)
- Targeted liposomes in fungi: Modifying the therapeutic index of amphotericin b by its incorporation into negatively charged liposomes (1995) (13)
- JAK 2-binding long noncoding RNA promotes breast cancer brain metastasis (2019) (13)
- Effector mechanisms of human monocyte-mediated tumor cytotoxicity in vitro: parameters of induction of cytotoxins from peripheral blood monocytes isolated by counterflow elutriation. (1986) (13)
- Liposomes in infectious diseases: present and future. (1989) (13)
- Formulation and Toxicity of Liposomes Containing Rifampicin (1993) (13)
- Potentiation of direct antitumor cytotoxicity and production of tumor cytolytic factors in human blood monocytes by human recombinant interferon-gamma and muramyl dipeptide derivatives (1986) (12)
- Therapy with human monoclonal anti-CTLA-4 antibody, CP-675,206, reduces regulatory T cells and IL-10 production in patients with advanced malignant melanoma (MM) (2005) (12)
- Delivery of negatively charged liposomes into the atheromas of Watanabe heritable hyperlipidemic rabbits (2010) (12)
- Integrated analyses identify a master microrna regulatory network for the mesenchymal subtype in serous ovarian cancer [Cancer Cell 23 (2013) 186-199] (2013) (12)
- Prophylaxis and treatment of experimental lung metastases in mice after treatment with liposome-encapsulated 6-O-stearoyl-N-acetylmuramyl-L-α-aminobutyryl-D-isoglutamine (1984) (12)
- In situ hybridization-based detection of microRNAs in human diseases (2014) (12)
- Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy. (2016) (12)
- Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2. (2016) (12)
- Liposomal polyene antibiotics. (2005) (12)
- Attenuation of amphotericin-B nephrotoxicity in the candidiasis rat model. (1991) (12)
- Correction to Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2 [Molecular Cell 61, 520-534, (2016)] (2016) (12)
- Single-agent liposomal all-trans-retinoic Acid as initial therapy for acute promyelocytic leukemia: 13-year follow-up data. (2014) (12)
- Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4 (2018) (11)
- Impact of adventitial neovascularisation on atherosclerotic plaque composition and vascular remodelling in a porcine model of coronary atherosclerosis. (2010) (11)
- Pharmacokinetics and tissue distribution of liposome-encapsulated cis-bis-N-decyliminodiacetato-1,2-diaminocyclohexane-platinum (II) (1986) (11)
- PKCδ Regulates Translation Initiation through PKR and eIF2α in Response to Retinoic Acid in Acute Myeloid Leukemia Cells (2012) (11)
- Diversity of lipid-based polyene formulations and their behavior in biological systems (2005) (11)
- Effects of free and liposomal amphotericin B and gramicidin S alone and in combination on potassium leakage from human erythrocytes and Candida albicans (1989) (11)
- ATP11B mediates platinum resistance in ovarian cancer. (2013) (11)
- Back to the Future: Rethinking the Great Potential of lncRNAS for Optimizing Chemotherapeutic Response in Ovarian Cancer (2020) (11)
- Therapeutic Drug Monitoring of Cyclosporine‐Lipoprotein Levels (1991) (10)
- New lives for old drugs: Liposomal drug delivery systems reduce the toxicity but not the potency of certain chemotherapeutic agents (1985) (10)
- Nephroprotective mechanism(s) of pentoxifylline: reduction of erythrocyte-mediated vascular congestion and inhibition of nitric oxide release. (1996) (10)
- Explainable Artificial Intelligence Reveals Novel Insight into Tumor Microenvironment Conditions Linked with Better Prognosis in Patients with Breast Cancer (2021) (10)
- Superoxide anion (O-2) production by peripheral blood monocytes in Hodgkin's disease and malignant lymphoma. (1985) (10)
- Enhancement of the treatment of experimental candidiasis with vascular decongestants. (1990) (10)
- Reciprocal positive selection for weakness - preventing olaparib resistance by inhibiting BRCA2 (2016) (9)
- Oligonucleotide therapy for hematological malignancies (1997) (9)
- Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) in mouse resident peritoneal macrophages, Kupffer cells, and hepatocytes. (1988) (9)
- Therapeutic targeting of PELP 1 prevents ovarian cancer growth and metastasis (2011) (9)
- Study of the natural history of immunoblastic lymphadenopathy and atypical immunoproliferative disorders. (1983) (8)
- PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR Pathway (2021) (8)
- Assessment of In Vivo siRNA Delivery in Cancer Mouse Models. (2016) (8)
- A genome‐scale screen reveals context‐dependent ovarian cancer sensitivity to miRNA overexpression (2015) (8)
- Interferon affects nuclear proteins in cells of clinically sensitive chronic myelogenous leukemia patients. (1990) (8)
- Issues in the development of gene therapy: preclinical experiments in E1A gene delivery. (1999) (8)
- Clinical significance of homologous recombination deficiency score testing in endometrial Cancer. (2021) (8)
- Nuclear Retinoid Receptors are Involved in N-(4-Hydroxyphenyl) Retinamide (Fenretinide)-Induced Gene Expression and Growth Inhibition in HL-60 Acute Myeloid Leukemia Cells (2004) (8)
- Targeting p 70 S 6 K Prevented Lung Metastasis in a Breast Cancer Xenograft Model (2010) (8)
- Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53‐altered tumors (2019) (8)
- Aptamers: Novel Therapeutics and Potential Role in Neuro-Oncology (2020) (8)
- Effects on the monocyte-macrophage system and antitumor activity against L1210 leukemia of cis-bis-cyclopentenecarboxylato-trans-R,R-1,2-diaminocyclohexane -platinum (II) encapsulated in multilamellar vesicles. (1986) (7)
- ATP 11 B mediates platinum resistance in ovarian cancer (2018) (7)
- Cellular uptake of antisense oligonucleotides. (2001) (7)
- Prophylaxis of Candida albicans infection with tuftsin. (1986) (7)
- A comparison of in vitro toxicity and antifungal efficacy of membrane-active drugs after liposome encapsulation. (1989) (7)
- Assessment ofall-trans retinoic acid (ATRA) efficacy as a single agent in primary lymphoid neoplasia (1999) (7)
- Antifungal activity of HWA-138 and amphotericin B in experimental systemic candidiasis (1991) (7)
- Retraction Note: miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2 (2020) (6)
- YAP1 and TAZ Activates mTORC1 Pathway by Regulating Amino Acid Transporters in hepatocellular carcinoma (2016) (6)
- Amphotericin B inhibits the serum-induced expression of tissue transglutaminase in murine peritoneal macrophages. (1986) (6)
- Profiling Long Noncoding RNA Expression Using Custom-Designed Microarray. (2016) (5)
- 1 Identification of FGFR 4 as a Potential Therapeutic Target for Advanced-Stage High-Grade Serous Ovarian Cancer (2012) (5)
- Genome-wide perturbations by miRNAs map onto functional cellular pathways, identifying regulators of chromatin modifiers (2015) (5)
- Corrigendum to ‘Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer’ [EBioMedicine 38 (2018) 100–112] (2020) (4)
- Erratum: Stress effects on FosB and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis (Journal of Biological Chemistry (2010) 285 (35462-35470) DOI: 10.1074/jbc.M110.109579) (2010) (4)
- Autophagy is Required to Regulate Mitochondria Renewal, Cell Attachment, and All-trans-Retinoic Acid-Induced Differentiation in NB4 Acute Promyelocytic Leukemia Cells. (2019) (4)
- Rational Drug Redesign to Overcome Drug Resistance in Cancer Therapy: Imatinib Moving Target (2008) (4)
- RNAi in Cancer Therapy (2013) (4)
- Antisense oligonucleotides and carriers for gene therapy (1993) (4)
- Endothelial p130cas confers resistance to anti-angiogenesis therapy (2020) (4)
- Activation of class I HLA expression by TNF‐alpha and gamma‐interferon is mediated through protein kinase C‐dependent pathway in CML cell lines (1991) (4)
- Cancer Therapy : Preclinical Enhancing Chemotherapy Response with Sustained EphA 2 Silencing Using Multistage Vector Delivery (2013) (4)
- Correction: Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer (2012) (4)
- Prophylaxis of Candida albicans Infection in Neutropenic Mice with Liposome-Encapsulated Amphotericin B (1984) (3)
- Silencing of p 130 Cas in Ovarian Carcinoma : A Novel Mechanism for Tumor Cell Death (2011) (3)
- Cancer Therapy : Preclinical Silencing Survivin Splice Variant 2 B Leads to Antitumor Activity in Taxane-Resistant Ovarian Cancer (2011) (3)
- In vivo vascular and tumor cell gene silencing with chitosan nanoparticles in ovarian carcinoma (2008) (3)
- Comprehensive epigenetic analysis of Notch pathway in high-grade serous ovarian cancer (2013) (3)
- NRG1/ERBB3 Pathway Activation Induces Acquired Resistance to XPO1 Inhibitors (2020) (3)
- Abstract 5468: JNK-1 inhibition leads to antitumor activity in ovarian cancer (2010) (3)
- Liposomal Delivery of P-Ethoxy Antisense Oligodeoxynucleotides in Chronic Myelogenous Leukemia (1996) (3)
- Abstract 142: SiRNA therapy against novel lncRNA NRCP: shutting down the fuel for cancer cells (2015) (3)
- Abstract LB-143: Sustained siRNA delivery by mesoporous silicon particles (2010) (3)
- Abstract P6-17-01: MicroRNA-34a suppresses breast cancer bone metastasis by inhibiting osteoclastogenesis and targeting tgif2 (2015) (3)
- CORRIGENDUM: GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma. (2021) (3)
- Erratum: Src activation by β-adrenoreceptors is a key switch for tumour metastasis (Nature Communications (2013) 4 (1403) DOI:10.1038/ncomms2413) (2013) (3)
- 34. Chronic stress promotes tumor growth through a Src-dependent mechanism in a mouse model of ovarian cancer (2008) (3)
- Noncoding RNAs: Novel Targets in Anticancer Drug Development (2018) (3)
- Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy. (2018) (3)
- The development of liposomal amphotericin B: An historical perspective (1998) (2)
- Targeting miR-155 to resensitize lung cancer to chemotherapy (2016) (2)
- Stress effects on FosB and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis. (2018) (2)
- Abstract 3532: Hypoxia is a master regulator of Drosha- and Dicer-dependent miRNA biogenesis in cancer (2014) (2)
- DELIVERY OF LIPOSOMAL FATTY ACID BINDING PROTEIN 4 SIRNA FOR THE TREATMENT OF ATHEROSCLEROSIS IN APOLIPOPROTEIN E-DEFICIENT MICE (2014) (2)
- Liposome-Mediated Delivery of Retinoids (1998) (2)
- Liposomal antisense oligonucleotides for cancer therapy. (2004) (2)
- EVALUATION OF AMPHOTERICIN B—CYCLOSPORINE INTERACTION IN THE RAT (1990) (2)
- Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer (2020) (2)
- Induction of Autophagy by Polyphenolic Compounds in Cancer: A Novel Strategy to induce cell death and to Treat Cancer (2012) (2)
- Targeting CDK7 reverses tamoxifen resistance through regulating stemness in ER+ breast cancer (2022) (2)
- Broad-Acting Therapeutic Effects of miR-29b-Chitosan on Hypertension and Diabetic Complications. (2022) (2)
- Abstract 1062: Sustained adrenergic signaling promotes intratumoral innervation through BDNF induction (2014) (2)
- Small Molecule Therapeutics Metronomic Docetaxel in PRINT Nanoparticles and EZH 2 Silencing Have Synergistic Antitumor Effect in Ovarian Cancer (2014) (2)
- Focal Adhesion KinaseTargeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian CarcinomaTherapy (2006) (2)
- Erratum: Influence of lipoproteins on renal cytotoxicity and antifungal activity of amphotericin B (Antimicrobial Agents and Chemotherapy 38:2 (224)) (1994) (2)
- Treatment and Pharmacokinetics of Liposomal-Amphotericin B Patients with Systemic Fungal Infections (1992) (2)
- Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens (2021) (1)
- Abstract 3564: Silencing pfkfb2 enhances paclitaxel sensitivity by modulating metabolism of p53 wt ovarian and breast cancer cells and xenografts (2017) (1)
- Effects of Liposomal Amphotericin B on Human Peripheral Blood Monocytes and Lymphocytes (1988) (1)
- Liposomes in Antimicrobial Therapy (1986) (1)
- Tumor cytotoxicity of human peripheral blood monocytes activated by muramyl dipeptide analogues (1982) (1)
- Cancer Therapy : Preclinical Clinical Cancer Research c-Jun-NH 2-kinase-1 Inhibition Leads to Antitumor Activity in Ovarian Cancer (2009) (1)
- Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens. (2018) (1)
- A Retrospective Analysis for Different Routes of Administration in Mice-Percutaneous Retro-Orbital, Jugular Catheter, Tail Vein and Femoral Cut Down Injections (2020) (1)
- Abstract 2273: Mechanistic and functional implications of FABP4 in ovarian cancer metastasis (2015) (1)
- Endothelial p130cas confers resistance to anti-angiogenesis therapy (2022) (1)
- Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L (2019) (1)
- Platelets reduce anoikis and promote metastasis by activating YAP1 signaling (2017) (1)
- All- trans -Retinoic acid (ATRA) and Arsenic Trioxide-Induced Expression and Regulation of Programmed Cell Death 4 (PDCD4) in Acute Promyelocytic Leukemia. (2004) (1)
- All-Trans-Retinoic Acid (ATRA) Induces Autophagy in Acute Promyelocytic Leukemia Cells. (2006) (1)
- Methylphosphonate liposomal antisense oligonucleotides and methods for their preparation and use. (1994) (1)
- RNA interference-based therapy and its delivery systems (2017) (1)
- Correction: Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy (2019) (1)
- Abstract 1618: Erythropoietin meets a new receptor (2011) (1)
- Single agent liposomal-encapsulated (Lipo) all-trans retinoic acid (ATRA) can cure patients with untreated acute promyelocytic leukemia (APL): An update and comparison with an ATRA+idarubicin induction regimen. (2004) (1)
- Abstract 4288: Targeted therapy against aldehyde dehydrogenase in ovarian cancer (2010) (1)
- Author Correction: miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2 (2019) (1)
- RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site. (2023) (1)
- Author Correction: Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma (2021) (1)
- Therapeutic Activity of Liposomal Amphotericin B in Systemic Mycoses (1990) (1)
- Abstract B30: The RNA-binding protein LARP1 is a cancer therapeutic target (2017) (1)
- Abstract 1988: Exosome-mediated ovarian cancer tumorigenesis mediated by miR1246/Rb/Cav1 axis (2017) (1)
- Tumor necrosis factor and c-fos expression in human peripheral-blood monocytes: expression is dependent on stage of in vitro differentiation. (1991) (1)
- Safety , Pharmacokinetics , and Tissue Distribution of Liposomal P-Ethoxy Antisense Oligonucleotides Targeted to Bcl-21 (1999) (1)
- Determination of dimyristolphosphatidylglycerol in human serum by liquid-liquid extraction and reversed-phase liquid chromatography (1994) (1)
- PKCδ Regulates Eukaryotic Initiation Factor eIF2α through PKR during Retinoic Acid-Induced Myeloid Cell Differentiation. (2006) (1)
- Author Correction: Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation (2022) (1)
- Correction: Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability (2020) (1)
- Gene therapy: Chemoprotection, immunoenhancement, and modification of tumor cells (1993) (1)
- Retraction Note: miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2 (2020) (1)
- The ubiquitin ligase EDD mediates platinum resistance and is a target for therapy in epithelial ovarian cancer (2011) (1)
- Abstract 3579: Long non-coding RNA ADAMTS9-AS2 inhibits ovarian tumor growth via Annexin A1 (2019) (1)
- Redirecting host preexisting influenza A virus immunity for cancer immunotherapy (2021) (1)
- Abstract 2983: Bisphosphonates: New strategies for targeting angiogenesis in ovarian cancer (2014) (1)
- Abstract 1125: Eukaryotic Elongation Factor 2 Kinase (eEF-2K) is a novel therapeutic target in BRCA1+ mutated breast cancer (2017) (1)
- Inactivating Mutations of the IK Gene Weaken Ku80/Ku70-Mediated DNA Repair and Sensitize Endometrial Cancer to Chemotherapy (2021) (1)
- Abstract 4468: Tumor vasculature targeting using cell-specific thioaptamer decorated chitosan nanoparticle (2014) (1)
- PO-289 Identification of microenvironmental regulation and therapeutic targeting of ongenic EF-2 kinase in pancreatic cancer (2018) (1)
- 1 Notch 3 Pathway Alterations in Ovarian Cancer (2014) (1)
- Author Correction: Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression (2020) (1)
- Amphotericin B (AmpB) inhibits the serum-induced expression of tissue transglutaminase (TGase) in mouse peritoneal macrophages (1985) (1)
- Prospects for liposomes as a novel drug delivery system (1985) (1)
- Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer (2012) (1)
- Abstract 1981: M2-macrophage derived exosomes mediates tumor progression via GATA3-IL-4-IL-13 axis in ovarian cancer (2019) (0)
- Proteoimic analysis of all-trans-retinoic acid treated acute promyelocytic leukemia cells using mass spectrometry and amino acid specific stable isotope labeling (2002) (0)
- Abstract 3787: Serotonin signaling plays a role in regulation of autophagy in breast cancer cells (2011) (0)
- N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration (2017) (0)
- Author Correction: Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation (2018) (0)
- Abstract #376: Arsenic trioxide induces autophagy in ovarian cancer cells (2009) (0)
- Oligonucleotides antisens de phosphonate de methyle de liposomes et procedes de preparation et d'utilisation (1994) (0)
- CLINICAL AND BIOLOGICAL RELEVANCE OF EZH2 IN TRIPLE NEGATIVE BREAST CANCER in the orthotopic MB-231 mouse model of breast carcinoma. Our results (2014) (0)
- Liposomes with anthracycline-containing medium. (1988) (0)
- Liposomes containing nystatin. (1988) (0)
- Abstract 3975: Pharmacologic inhibition of the ΔNp63/DGCR8 axis as a novel therapeutic strategy for p53-deficient and mutant tumors (2015) (0)
- Editor's Note: Functional Roles of Src and Fgr in Ovarian Carcinoma (2021) (0)
- ATP11B mediates platinum resistance in ovarian cancer. (2021) (0)
- Role of increased n-acetylaspartate levels in epithelial ovarian cancer (2015) (0)
- Mononuclear phagocyte system cytotoxins: a review. (1985) (0)
- A potential use of Indium-111 labeled monocytes as a tumor imaging agent (1984) (0)
- Stress and the metastatic switch in epithelial ovarian carcinoma (2011) (0)
- Mepartricine a liposome incorpore (1988) (0)
- Salt-Inducible Kinase 2 Co uples Ovarian Cancer Cell Metabolism with Survival at the Adipocyte-Rich Metastatic Niche Graphical (2016) (0)
- Abstract 1952: Adverse effects of erythropoietin stimulates tumor growth via EphB4 (2015) (0)
- Foerfarande Foer framstaellning of at antitumoer chemother anvaendbara hydrophobes platinum (II) fyrkoordinatkomplex. (1987) (0)
- Abstract 5466: Integrative TCGA analyses identify Basonuclin1 (BNC1) as a key mediator for platinum resistance (2015) (0)
- Increased superoxide anion production by liposome-encapsulated muramyl dipeptide primed human monocyte (1982) (0)
- HYDROPHOBIC CIS-PLATINUM COMPLEXES EFFICIENTLY INCORPORATED INTO LIPOSOMES (1999) (0)
- Phase I Clinical and Pharmacological Study of Liposome-entrapped ciÃ-- Bis-neodecanoato-Ã-ra / iÃ-- ^ A-l ^-diaminocyclohexanePlatinum ( II ) 1 (2006) (0)
- Selective activation of Notch3 in high-grade serous ovarian cancer (2014) (0)
- Abstract 5377: Intragenic DNA methylation and increased gene expression: New directions from pan-cancer analysis (2017) (0)
- Abstract 1044: Silencing p130cas in ovarian carcinoma induces autophagic cell death (2010) (0)
- Abstract 2094: Translating EPHARNA (DOPC nanoliposomal EphA2-targeted siRNA) to the clinic (2016) (0)
- Abstract 2982: Macrophages modulate adaptive resistance to anti-angiogenic therapy (2014) (0)
- Abstract 2359: Adrenergic regulation of MCP-1 leads to enhanced macrophage recruitment and ovarian carcinoma growth (2015) (0)
- Effects ofFreeandLiposomal Amphotericin BandGramicidin S AloneandinCombination on Potassium Leakage fromHuman Erythrocytes andCandida albicans (1989) (0)
- Abstract 1649: The E3 ubiquitin ligase EDD regulates platinum resistance and is a novel therapeutic target for epithelial ovarian cancer (2011) (0)
- Abstract 6001: Epigenetic regulation of BARD1 confers resistance to anti-VEGF therapy in ovarian cancer (2023) (0)
- Liposomal antisense methyl phosphonate oligo-nucleotides and process for their preparation and their use (1994) (0)
- Abstract 3686: Regulatory role cancer stem cells (CSCs)-derived exosomal miRNAs in ovarian cancer growth and progression (2019) (0)
- Abstract 539: Downregulation of hnRNP A1 by miRNAs as a new mechanism of survival in ovarian cancer (2014) (0)
- Erratum: ATP11B mediates platinum resistance in ovarian cancer (Journal of Clinical Investigation (2013) 123:5 (2119-2130) DOI: 10.1172/JCI65425) (2013) (0)
- microRNAs and Other Non-Coding RNAs as Targets for Anticancer Drug Development (2023) (0)
- Editor's Note: Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles (2021) (0)
- Abstract 1735: Silencing survivin splice variant 2B leads to antitumor activity in taxane-resistant ovarian cancer (2011) (0)
- Prospects for Liposomes as Drug Carriers (1987) (0)
- Abstract 5517: Targeting anticancer therapeutics: A role for reconstituted high density lipoprotein (rHDL) (2010) (0)
- Determination of dimyristoylphosphatidylglycerol in human serum by liquid-liquid extraction and reversed-phase liquid chromatography. (1994) (0)
- Abstract 2642: EF2-kinase (EF2K): A novel molecular target in ovarian and pancreatic cancers (2015) (0)
- Death associated protein 5 (DAP5/p97/NAT1) is upregulated during retinoic acid-induced cell differentiation and DAP5/p86 is associated with arsenic trioxide-induced apoptosis in promyelocytic leukemia cells: A possible mechanism of leukemia cell differentiation and apoptosis (2006) (0)
- Abstract 4668: Silencing PTGER3 enhances chemotherapeutic responses (2016) (0)
- Proliposomales powder for polyenliposomen and process for its production. (1992) (0)
- Death Associated Protein 5 (DAP5/p97/NAT1) Contributes to Retinoic Acid-Induced Granulocytic Differentiation and Arsenic Trioxide Induced Apotosis through Inhibition of PI3K/Akt/mTOR Pathway in Acute Promyelocytic Leukemia Cells: A Novel Mechanism. (2007) (0)
- Hydrophobes cis platinakomplex, Vilka operationally inkorporerats i liposomer. (1987) (0)
- Abstract 2066: Delivery of 2`F-PS2 PTGER3 siRNA-DOPC enhances anti-tumoral activity in cisplatin resistant ovarian cancer model (2017) (0)
- p38 MAPK Signaling Mediates Retinoic Acid-Induced Expression of a Novel Tumor Suppressor Protein Programmed Cell Death 4 (PDCD4) in Acute Promyelocytic Leukemia Cells. (2006) (0)
- Abstract 473: PRKRA/PACT expression promotes chemoresistance in mucinous ovarian cancer (2017) (0)
- Abstract 368: Next generation DNA aptamers with prolonged stability and antitumor activity (2019) (0)
- Abstract 5048: Platelet FAK is a critical regulator of tumor growth after withdrawal of anti-angiogenic therapy (2016) (0)
- Discovery of an alternate erythropoietin receptor: The Eph connection (2012) (0)
- Abstract 1406: Evoking potent RNAi response using novel 2′-OMe-phosphorodithioated modified siRNAs (2014) (0)
- Liposomal administration of amphotericin B reduces toxicity (1991) (0)
- Preparation of serotonins and related compounds for the treatment of cancer (2013) (0)
- Abstract 677: Targeting the survivin splice variant 2β in taxane-resistant ovarian cancer (2010) (0)
- PNAS Plus Significance Statements (2013) (0)
- Abstract P2-22-04: Functional effect of miR-1307-3p on breast cancer progression (2023) (0)
- Abstract 5091: Activity of Bcl-2 antisense therapeutic in aggressive non-Hodgkin's lymphoma (2017) (0)
- Oligonucleotides antisens wt1 inhibant le cancer du sein (2003) (0)
- Clinical Pharmacology of ""Tc-labeled Liposomes in Patients with Cancer1 (2006) (0)
- Abstract 884: Basonuclin1 (BNC1): A novel therapeutic target in ovarian cancer identified through integrative TCGA-based functional genomic analysis (2012) (0)
- Inhibiting the growth of chronic myelogenous leukemic cells by antisense oligonucleotides which are targeted to Crkl (1997) (0)
- Hydrophobic cis-platinum complexes, and liposomes comprising such complexes and methods for preparing such complexes and liposomes (1987) (0)
- with monocytic differentiation Expression of c-fos, c-myb, and c-myc in human monocytes: correlation (2011) (0)
- Id2 en tant que cible dans le cancer colorectal (2008) (0)
- Abstract 3269: Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery . (2013) (0)
- Editor's Note: Therapeutic Targeting of ATP7B in Ovarian Carcinoma (2021) (0)
- The “EX” and the “SOMA”: How They Communicate (2014) (0)
- Development of novel modified aptamers to target Axl receptor in ovarian cancer (2018) (0)
- A Glucose G 6 P F 6 P GAP DHAP 3 PG Pyruvate Acetyl-CoA Citrate α-ketoglutarate Succinate Fumarate Malate OAA Aspartate Glutamate Glutamine PPP pathway Lactate (2016) (0)
- Abstract 4457: In Search of a novel EPO receptor: The clinical significance of the Eph connection (2011) (0)
- THE EFFECTS OF FATTY ACID BINDING PROTEIN 4 ON ATHEROSCLEROTIC PLAQUE APOPTOSIS AND AUTOPHAGY (2014) (0)
- Systemic Delivery of Liposome-Incorporated Adrenomedullin Receptor (ADMR) Small Interfering RNA Against Tumor and Its Microenvironment Reduced Pancreatic Tumor Growth (2009) (0)
- Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer (2023) (0)
- Nystatine a liposome incorpore (1988) (0)
- Induction of Autophagic Cell Death by Targeting Bcl-2 as a Novel Therapeutic Strategy in Breast Cancer (2012) (0)
- Abstract 5108: Silencing of Bcl-2 by liposomal siRNA enhances Doxorubicin-induced autophagy and inhibits in vivo tumor growth of ER(−) and ER(−) breast cancers (2010) (0)
- Abstract 507: MiR-873 functions as a potential tumor suppressor in pancreatic cancer by targeting KRAS (2018) (0)
- NANOPARTICULES À DEUX CONSTITUANTS (2016) (0)
- Allele-Specific Reprogram ming of Cancer Metabolism by the Long Non-coding RNA CCAT 2 Graphical (2016) (0)
- In liposome-incorporated hydrophobic cis-platinum complex. (1986) (0)
- Distribution of 99mTC-labeled multilamellar liposomes (MLV) in patients (pts) with Hodgkin disease (HD) (1985) (0)
- Small Molecule Therapeutics Bisphosphonates Inhibit Stellate Cell Activity and Enhance Antitumor Effects of Nanoparticle Albumin – Bound Paclitaxel in Pancreatic Ductal Adenocarcinoma (2014) (0)
- RETRACTED ARTICLE: miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2 (2014) (0)
- Abstract 763: Exosomal miR-6126 as a novel tumor suppressor in ovarian cancer (2016) (0)
- Human monocyte cytotoxins (1985) (0)
- Erratum to: Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer (2012) (0)
- Abstract 5433: Knockdown of the glycolytic enzyme PFKFB2 induces growth inhibition and enhances paclitaxel sensitivity in ovarian cancer cells. (2013) (0)
- Induction of tissue transglutaminase (TGase) in human monocytoid cells (THP-1) during retinoid and phorbol ester-induced differentation (1985) (0)
- Abstract 504: miR-484 acts as an “oncomiR” in triple negative breast cancer cells to promote tumor growth and progression by targeting HOXA5 (2018) (0)
- Novel tumor suppressor protein programmed cell death 4 (PDCD4) suppresses activity of PI3K/Akt pathway and regulates expression of p27 (Kip1), c-myc, DAP5 and Willm’s tumor (WT1) in acute myeloid leukemia cells (2007) (0)
- Abstract 2591: miR-193b is a novel regulator of Inhibition of Notch signaling by for targeting cancer stem cell and tumor microenvironment (2019) (0)
- Formulation and use of carotenoid in cancer treatment (1993) (0)
- Abstract 88: Targeting Bcl-XL enhances arsenic-induced cell death in ovarian cancer cells (2010) (0)
- ZNF306, a novel zinc finger transcription factor, drives colon cancer progression – An alternate genetic pathway in tumor progression? (2006) (0)
- Bone protection by inhibition of microRNA-182 (2018) (0)
- Promyelocytic Leukemia Reveals Systematic Post-Transcriptional Control Mechanisms in Acute Comparative Proteomic Analysis of All-trans-Retinoic Acid Treatment (2013) (0)
- Abstract 3669: PELP1: A novel therapeutic target for ovarian cancer progression and metastasis (2010) (0)
- Abstract B47: Therapeutic KRAS silencing in lung and colon cancer models (2014) (0)
- Compositions et methodes associees aux formulations de lipide:emodine (2003) (0)
- Abstract 5786: Grabbing GRB2: The use of liposome-incorporated Grb2 antisense oligonucleotides as a novel therapy in gynecologic malignancies (2018) (0)
- Assessment of In Vivo siRNA Delivery in Cancer Mouse Models. (2021) (0)
- Regulation of gene expression by tumor necrosis factor-alpha and interferon-gamma in chronic myelogenous leukemia. (1990) (0)
- Monocytîc differentiation signals by tetradecanoyl phorbol acetate and retinoic acid differ in production of tumor necrosis factor-atext (1996) (0)
- Abstract 6331: Cloaking VEGF in small extracellular vesicles as a cause of adaptive resistance to anti-VEGF therapy (2020) (0)
- Abstract 4959: Targeting pancreatic stellate cells (PSC) to treat pancreatic cancer. (2013) (0)
- Abstract 1811: Breaking scaffolds: Targeting paxillin in ovarian cancer (2010) (0)
- Abstract 200: Long lasting inhibition of TGF-β receptor Type 1 inhibitor (TGF-β R1) for treatment of pancreatic cancer (2017) (0)
- PI3K/Akt/mTOR pathway constitutively suppresses expression of programmed cell death 4 (PDCD4) tumor suppressor protein in acute myeloid leukemia and breast cancer cells (2007) (0)
- LABELING AND DISTRIBUTION OF CANDIDA ALBICANS IN MICE.: A3 (1983) (0)
- RNAi: A New Paradigm in Cancer Gene Therapy (2010) (0)
- miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas (2017) (0)
- Prophylaxis of Infection in Neutropenic Mice with Liposome-Encapsulated Amphotericin B. (1984) (0)
- Abstract 5057: Gene expression profile of chemoresponse of microdissected papillary serous tumors of the ovary identifies POLH and REV3L as potential therapeutic targets (2012) (0)
- PHARMACOKINETICS, TISSUE DISTRIBUTION, OLIGONUCLEOTIDES INCORPORATED IN LIPOSOMES AND SAFETY OF P-ETHOXY (1998) (0)
- Author Correction: Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression (2020) (0)
- Therapeutics , Targets , and Chemical Biology Notch 3 Pathway Alterations in Ovarian Cancer (2014) (0)
- Abstract 937: Molecular dynamics of SrcS17 activation in chronic stress-induced tumor growth (2011) (0)
- Cancer and the Heart (2011) (0)
- Protective effect of liposomal-amphotericin-B (L-AMPB) on murine macrophages and lymphocytes (1985) (0)
- Systemic fungal infections in childhood leukemia: treatment with liposomal amphotericin B (L AmpB). (1990) (0)
- Abstract 2992: Zoledronic acid inhibits angiogenesis through Rac1 inactivation in ovarian cancer (2014) (0)
- HOMING PATTERN OF INDIUM‐111 PERIPHERAL BLOOD MONOCYTES IN RATS. (1984) (0)
- Corrigendum to “PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis” [EBioMedicine 40 (2019) 290-304] (2022) (0)
- Abstract AP21: A NOVEL TARGET FOR OVERCOMING ADAPTIVE RESISTANCE TO ANTI-ANGIOGENIC THERAPY IN OVARIAN CANCER (2019) (0)
- Correction: Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver (2020) (0)
- Abstract P2-22-03: Effect of miR-660-5p in breast cancer progression (2023) (0)
- Tumor cell β adrenergic receptor dependence for chronic stress effects on ovarian cancer growth (2006) (0)
- Abstract 4262: MiR-873 is the master regulator of autophagy genes through a novel negative feedback mechanism mediated by Elongation factor 2 kinase (eEF-2K) and suppresses tumor growth and progression of triple negative breast cancer (2019) (0)
- Abstract 1550: Elucidating the role of ADAMTS9AS2 lncRNA in ovarian cancer (2022) (0)
- Isotope-coding quatitative proteomics reveals that peroxiredoxins and other mitochondrial effectors, play a role in proliferation and apoptosis of acute promyelocytic leukemia cells following ATRA treatment. (2007) (0)
- Liposomal-All-trans-Retinoic Acid in the Treatment of Acute Promyelocytic Leukemia (2005) (0)
- Cancer Therapy: Preclinical Therapeutic Targeting of ATP7B in Ovarian Carcinoma (2009) (0)
- Reticulosarcoma with c / sBis-neodecanoato-frans-/ ? , / M , 2-diaminocyclo-hexaneplatinum ( II ) Encapsulated in IV ! uItilameIlar Vesicles 1 (2006) (0)
- Molecular Cancer Therapeutics Targeting p 70 S 6 K Prevented Lung Metastasis in a Breast Cancer Xenograft Model (2010) (0)
- Abstract 1426: Cyclooxygenase-2 (COX-2) utilizes Jun N-terminal kinases to induce invasion but not tamoxifen resistance in MCF-7 breast cancer cells (2011) (0)
- Abstract 4144: Role of CTGF in hyperthermia resistance in ovarian and uterine cancers (2017) (0)
- Abstract B68: Erythropoietin stimulates ovarian tumor growth via EphB4. (2016) (0)
- linical Development verging Evidence for Efficacy from Parallel EphB 4-Ther geted Approaches in Ovarian Carcinoma (2010) (0)
- Downregulation of Peroxiredoxin III Contributes to Arsenic Trioxide-Induced Apoptosis in APL. (2007) (0)
- NOTES Prophylaxis ofCandida albicans Infection inNeutropenic Micewith (1984) (0)
- Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy (2021) (0)
- Programmed cell death 4 (pdcd4) tumor suppressor protein is constitutively repressed by PI3K/Akt/mTOR pathway, NF-kb and c-myc in acute myeloid leukemia cells (2008) (0)
- Abstract 2036: Overcoming platinum-resistance in ovarian cancer via targeting basonuclin1 (BNC1). (2013) (0)
- Pharmacokinetics of intravenous liposomal all-trans-retinoic acid (ATRA) compared to oral atra in healthy subjects (2000) (0)
- Heterogeneity of the production of hydrogen peroxide (H2O2) by human peripheral blood monocytes (HPBM); in vitro maturation determines production levels (1985) (0)
- Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update (2023) (0)
- Abstract 2720: Enhancing oral delivery of plant-derived vesicles (2023) (0)
- Abstract LB-311: Exosomal gain-of-function p53 protein promotes cancer-associated phenotype (2019) (0)
- Abstract 5684: Sustained gene silencing by liposomal siRNA incorporated mesoporous silicon particles (2012) (0)
- Enhancing oral delivery of plant-derived vesicles for colitis. (2023) (0)
- Author Correction: TP53 loss creates therapeutic vulnerability in colorectal cancer (2021) (0)
- PKCδ Regulates Retinoic Acid-Induced Myeloid Cell Differentiation through Eukaryotic Initiation Factor Alpha (eIF2α). (2007) (0)
This paper list is powered by the following services:
